chrX-147981517-G-A
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_152578.3(FMR1NB):c.115G>A(p.Glu39Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000132 in 1,210,057 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 5 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_152578.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FMR1NB | NM_152578.3 | c.115G>A | p.Glu39Lys | missense_variant | 1/6 | ENST00000370467.8 | NP_689791.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FMR1NB | ENST00000370467.8 | c.115G>A | p.Glu39Lys | missense_variant | 1/6 | 1 | NM_152578.3 | ENSP00000359498.3 |
Frequencies
GnomAD3 genomes AF: 0.0000179 AC: 2AN: 111750Hom.: 0 Cov.: 22 AF XY: 0.0000295 AC XY: 1AN XY: 33938
GnomAD3 exomes AF: 0.0000273 AC: 5AN: 182874Hom.: 0 AF XY: 0.0000593 AC XY: 4AN XY: 67504
GnomAD4 exome AF: 0.0000127 AC: 14AN: 1098253Hom.: 0 Cov.: 34 AF XY: 0.0000110 AC XY: 4AN XY: 363609
GnomAD4 genome AF: 0.0000179 AC: 2AN: 111804Hom.: 0 Cov.: 22 AF XY: 0.0000294 AC XY: 1AN XY: 34002
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 08, 2024 | The c.115G>A (p.E39K) alteration is located in exon 1 (coding exon 1) of the FMR1NB gene. This alteration results from a G to A substitution at nucleotide position 115, causing the glutamic acid (E) at amino acid position 39 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at